Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp)

NCT02437409 is registered in ClinicalTrials.gov with Phenox GmbH as lead sponsor.

NCT NCT02437409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02437409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp)
Lead sponsor
Phenox GmbH
Phase
Observational
Overall status
Completed
Start date
February 28, 2013
Completion date
August 31, 2015
Enrollment
115 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

stroke